Background to SarcoSIGHT

What is SarcoSIGHT?

The SarcoSIGHT trial will include 500 patients across 17 UK sites to compare two different surgical techniques that are currently used in the NHS for sarcoma surgery. The aim of this trial is to find out if one technique is better than the other for removing the whole tumour.

Is it safe?

Participant’s hospital stay or care will not change as a result of taking part in the SarcoSIGHT trial. In addition, hospital staff closely monitor the health of all participants and make sure they are not put at risk. Indocyanine green (ICG) has been used for many years for other clinical purposes and is known to be very safe unless you have an allergy to shellfish or iodine.

Want to know more?

More detailed information about the SarcoSIGHT trial can be found on the ISRCTN registry here.

Or on cancer research here.

Details on NIHR are here.

Details on Sarcoma UK are here.

Details on Bone Cancer Research Trust are here.

Further Support:

For further support and information regarding sarcoma’s please visit:

Sarcoma UK here.

Bone Cancer Trust UK here.

Further Support:

For further support and information regarding sarcoma’s please visit:

Sarcoma UK here.

Bone Cancer Trust UK here.